Clinical Trials Browser

Lymphoma, B-Cell, Marginal Zone × Maintenance × 90 days × Clear all

NCT04542824 2026-03-03

EPCORE™ NHL-3

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT07372365 2026-01-28

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

Phase 2 Recruiting

Lymphoma, B-Cell, Marginal Zone